Logo image of ACB.CA

AURORA CANNABIS INC (ACB.CA) Stock Overview

Canada - TSX:ACB - CA05156X8504 - Common Stock

7.34 CAD
+0.23 (+3.23%)
Last: 10/24/2025, 7:00:00 PM

ACB.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap412.88M
Revenue(TTM)357.88M
Net Income(TTM)-19461000
Shares56.25M
Float56.22M
52 Week High9.9
52 Week Low4.95
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.35
PEN/A
Fwd PE15.63
Earnings (Next)11-06 2025-11-06/bmo
IPO2007-09-26
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


ACB.CA short term performance overview.The bars show the price performance of ACB.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10

ACB.CA long term performance overview.The bars show the price performance of ACB.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40 -60

The current stock price of ACB.CA is 7.34 CAD. In the past month the price increased by 6.69%. In the past year, price decreased by -10.92%.

AURORA CANNABIS INC / ACB Daily stock chart

ACB.CA Latest News, Press Relases and Analysis

ACB.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.64 3.22B
TLRY.CA TILRAY BRANDS INC N/A 2.34B
CRON.CA CRONOS GROUP INC 50.57 1.36B
DHT-UN.CA DRI HEALTHCARE TRUST 7.05 836.13M
WEED.CA CANOPY GROWTH CORP N/A 642.67M
DHT-U.CA DRI HEALTHCARE TRUST 4.98 591.08M
GUD.CA KNIGHT THERAPEUTICS INC N/A 581.13M
TSND.CA TERRASCEND CORP N/A 417.81M
HITI.CA HIGH TIDE INC N/A 405.93M
CPH.CA CIPHER PHARMACEUTICALS INC 22.64 366.89M
OGI.CA ORGANIGRAM GLOBAL INC N/A 331.80M
NGEN.CA NERVGEN PHARMA CORP N/A 280.43M

About ACB.CA

Company Profile

ACB logo image Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Company Info

AURORA CANNABIS INC

2207 90B Street Sw

Leduc ALBERTA T9E 0V6 CA

CEO: Miguel Martin

Employees: 1101

ACB Company Website

ACB Investor Relations

Phone: 16043625207

AURORA CANNABIS INC / ACB.CA FAQ

Can you describe the business of AURORA CANNABIS INC?

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


Can you provide the latest stock price for AURORA CANNABIS INC?

The current stock price of ACB.CA is 7.34 CAD. The price increased by 3.23% in the last trading session.


Does ACB stock pay dividends?

ACB.CA does not pay a dividend.


How is the ChartMill rating for AURORA CANNABIS INC?

ACB.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the expected growth for ACB stock?

The Revenue of AURORA CANNABIS INC (ACB.CA) is expected to grow by 8.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the market capitalization of ACB stock?

AURORA CANNABIS INC (ACB.CA) has a market capitalization of 412.88M CAD. This makes ACB.CA a Small Cap stock.


What is the ownership structure of AURORA CANNABIS INC (ACB.CA)?

You can find the ownership structure of AURORA CANNABIS INC (ACB.CA) on the Ownership tab.


ACB.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to ACB.CA. When comparing the yearly performance of all stocks, ACB.CA is a bad performer in the overall market: 78.79% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ACB.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ACB.CA. The financial health of ACB.CA is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACB.CA Financial Highlights

Over the last trailing twelve months ACB.CA reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 44.79% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2.32%
ROE -3.53%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%-307.69%
Sales Q2Q%17.48%
EPS 1Y (TTM)44.79%
Revenue 1Y (TTM)28.42%

ACB.CA Forecast & Estimates

9 analysts have analysed ACB.CA and the average price target is 8.08 CAD. This implies a price increase of 10.13% is expected in the next year compared to the current price of 7.34.

For the next year, analysts expect an EPS growth of -288.53% and a revenue growth 8.72% for ACB.CA


Analysts
Analysts73.33
Price Target8.08 (10.08%)
EPS Next Y-288.53%
Revenue Next Year8.72%

ACB.CA Ownership

Ownership
Inst Owners15.09%
Ins Owners0.03%
Short Float %N/A
Short RatioN/A